COMMUNITY - the COVID-19 Immunity Study
Key facts
- Who runs it
- Danderyd Hospital
- Where
- Sweden2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 2,420 people enrolled
- Started
- 15 Apr 2020
- Expected to end
- Apr 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Blood sampling
- Mucosal sampling
- PCR-test
- Record updated
- 7 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Health care workers: Employment at Danderyd hospital at time of enrollment
- COVID-19 patients: Admitted to Danderyd Hospital with confirmed SARS-CoV-2 infection at time of enrollment
Who cannot take part
- No exclusion criteria
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The principal aim of the COMMUNITY study is to investigate immune responses following SARS-CoV-2 infection and/or vaccination in healthcare workers and hospitalized COVID-19 patients. The study aims to enroll a total of 5,000 healthcare workers and 500 COVID-19 patients. All participants are enrolled at Danderyd Hospital in Stockholm, Sweden. Participants will be followed every four months with blood and mucosal sampling in addition to demographic and clinical data provided by the participants and from national registries.
Read full original descriptionShow less
Primary outcome:
- Antibody responses in blood and mucosa following SARS-CoV-2 infection and/or vaccination
Secondary outcomes:
* Cellular immune responses following SARS-CoV-2 infection and/or vaccination * Antibody responses in blood and mucosa following following Influenza A/B infection and/or vaccination * Antibody responses in blood and mucosa following following RSV A/B infection
Blood and mucosal samples are collected every 4 months and at tighter intervals in sub studies. PCR testing is conducted upon symptoms of respiratory infections and with regular intervals regardless of symptomatology in sub studies. Participants provide detailed demographic and clinical data through a smart phone application-based questionnaire. Data on infection and vaccination history is collected from national registries
The 2 groups in the trial
- The COMMUNITY cohort - healthcare workers
5000 healthcare workers employed at Danderyd Hospital at time of enrollment
Treatment: Blood sampling, Mucosal sampling, and PCR-test
- The COMMUNITY cohort - COVID-19 patients
500 patients admitted to Danderyd Hospital with confirmed SARS-CoV-2 infection
Treatment: Blood sampling, Mucosal sampling, and PCR-test
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 October 2026